FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387563005: Butalbital (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461741011 Butalbital (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481653010 Butalbital en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492155018 Allylbarbital en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
796391000172118 butalbital fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Butalbital (substance) Is a Barbiturate (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Butalbital measurement Component True Butalbital (substance) Inferred relationship Some 1
Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Butalbital 50 mg and paracetamol 650 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Butalbital 50 mg and paracetamol 325 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Product containing butalbital (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 1
Product containing aspirin and butalbital and caffeine and codeine phosphate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Product containing butalbital and caffeine and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 3
Product containing butalbital and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 2
Product containing butalbital and caffeine and codeine phosphate and paracetamol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Product containing aspirin and butalbital and caffeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 3
Fioricet with codeine 325mg/50mg/40mg/30mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 3
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 3
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 3
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 1
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 1
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 1
Butalbital 50 mg and paracetamol 650 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 1
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 2
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 2
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 3
Butalbital 50 mg and paracetamol 325 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 1
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 1
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 1
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 4
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 4
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 1
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 1
Butalbital 50 mg and paracetamol 650 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 2
Butalbital 50 mg and paracetamol 650 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 2
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 1
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 1
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 1
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 1
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 2
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 2
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 2
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 2
Butalbital 50 mg and paracetamol 325 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Butalbital (substance) Inferred relationship Some 2
Butalbital 50 mg and paracetamol 325 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 2
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Butalbital (substance) Inferred relationship Some 2
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 3
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Butalbital (substance) Inferred relationship Some 2
Aspirin- and butalbital- and caffeine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 3
Product containing aspirin and butalbital and caffeine and codeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 4
Aspirin- and butalbital- and caffeine- and codeine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 4
Butalbital 50 mg and paracetamol 325 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Butalbital (substance) Inferred relationship Some 1
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Butalbital (substance) Inferred relationship Some 2
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Butalbital (substance) Inferred relationship Some 1
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Butalbital (substance) Inferred relationship Some 3
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Butalbital (substance) Inferred relationship Some 1
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Butalbital (substance) Inferred relationship Some 1
Butalbital 50 mg and paracetamol 650 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Butalbital (substance) Inferred relationship Some 1
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Butalbital (substance) Inferred relationship Some 2
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Butalbital (substance) Inferred relationship Some 2
Product containing butalbital and caffeine and codeine and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 4
Product containing butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 4
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 3
Product containing butalbital and caffeine and paracetamol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 3
Product containing butalbital and paracetamol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 2
Aspirin and butalbital and caffeine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 3
Product containing only butalbital and caffeine and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 3
Product containing only aspirin and butalbital and caffeine and codeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 4
Product containing only butalbital (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 1
Butalbital and caffeine and codeine and paracetamol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 4
Product containing only butalbital and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 2
Product containing only aspirin and butalbital and caffeine and codeine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 4
Product containing only aspirin and butalbital and caffeine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 3
Product containing only butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 4
Product containing only butalbital and caffeine and paracetamol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 3
Product containing only butalbital and paracetamol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Butalbital (substance) Inferred relationship Some 2
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 2
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 2
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 4
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 4
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 4
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 2
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 2
Butalbital 50 mg and paracetamol 650 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 2
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 3
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 3
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 3
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 3
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 3
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 3
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 3
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Butalbital (substance) Inferred relationship Some 3
Butalbital 50 mg and paracetamol 325 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Butalbital (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start